Reference : Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgiqu...
Scientific journals : Article
Human health sciences : Cardiovascular & respiratory systems
Human health sciences : Pediatrics
http://hdl.handle.net/2268/232328
Depistage neonatal de la mucoviscidose : vers une implementation nationale en Belgique en 2019.
French
[en] Neonatal screening for cystic fibrosis : towards a national implementation in Belgium in 2019
BOBOLI, Hedwige [Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie >]
BOEMER, François [Centre Hospitalier Universitaire de Liège - CHU > Unilab > Laboratoire Biochimie Génétique >]
MASTOURI, Meriem [Centre Hospitalier Universitaire de Liège - CHU > Département de Pédiatrie > Service de pédiatrie >]
Seghaye, Marie-Christine mailto [Université de Liège - ULiège > Département des sciences cliniques > Pédiatrie cardiologique et pneumologique >]
Oct-2018
Revue Médicale de Liège
73
10
497-501
Yes (verified by ORBi)
National
0370-629X
2566-1566
Belgium
[en] Belgium ; Newborn screening ; Cystic fibrosis
[en] Cystic fibrosis has in Belgium a prevalence of 1/2.850 births, with a median age at diagnosis of 7 months according to the latest data from the Belgian registry of 2015. In our country, the diagnosis of cystic fibrosis is always based on signs and symptoms of the disease. However, because the scientific literature has largely demonstrated the benefits of neonatal screening for cystic fibrosis, it will be implemented in Belgium before the end of 2019. The screening programme should be framed by strict quality criteria in order to obtain the best performance with the least possible inconvenience.
http://hdl.handle.net/2268/232328

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
Dépistage néonatal de la mucoviscidose.pdfPublisher postprint266.89 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.